Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Karuna Therapeutics, Inc. | Chief Financial Officer | Common Stock | 0 | $0 | $330.00 | Mar 18, 2024 | Direct |
Karuna Therapeutics, Inc. | Chief Financial Officer | Restricted Stock Units | 0 | $0 | $330.00 | Mar 18, 2024 | Direct |
Karuna Therapeutics, Inc. | Chief Financial Officer | Option (right to buy) | 0 | $0 | $160.91 | Mar 18, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
KRTX | Karuna Therapeutics, Inc. | Mar 18, 2024 | 8 | -$16.9M | 4 | Mar 18, 2024 | Chief Financial Officer |
KRTX | Karuna Therapeutics, Inc. | Feb 13, 2024 | 2 | -$88.4K | 4 | Feb 15, 2024 | Chief Financial Officer |
KRTX | Karuna Therapeutics, Inc. | Sep 29, 2023 | 2 | $0 | 4 | Oct 3, 2023 | Chief Financial Officer |
KRTX | Karuna Therapeutics, Inc. | Sep 29, 2023 | 0 | $0 | 3 | Oct 3, 2023 | Chief Financial Officer |